Study title: Open label pharmacokinetic and safety evaluation of single oral dose (1,2mg/kg) of dolasetron mesylate in children undergoing elective and uncomplicated surgery under general anesthesia - Keung - 9 February 1995
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Pathological Conditions, Signs and Symptoms [C23] | |||||
Brands: | |||||
MAH holders: | |||||
Assessment: | |||||
Active substance: DOLASETRON | |||||
ATC code: | |||||
Document link: | |||||
Document date: | |||||
Study number: - | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |